Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor.
Thiago Guarato Rodrigues CostaMarcelo KatzPedro Alves Lemos NetoJoão Carlos de Campos GuerraMarcelo FrankenAntonio Eduardo Pereira PesaroPublished in: Einstein (Sao Paulo, Brazil) (2022)
Low platelet reactivity was very common in patients with acute myocardial infarction submitted to dual antiplatelet therapy with ticagrelor and aspirin. Findings of this study justify the investigation of less intensive platelet inhibition strategies aimed at reducing the risk of bleeding in this population, such as lower dose regimens or monotherapy with P2Y12 inhibitors.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute myocardial infarction
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- atrial fibrillation
- left ventricular
- heart failure
- low dose
- type diabetes
- combination therapy
- newly diagnosed
- study protocol